Global Generic Drug Litigation Updates 2018: Opportunities for Generic Companies Based on the Latest Para IV Events – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Generic Drug Litigation Updates 2018: Opportunities for Generic
Companies Based on the Latest Para IV Events”
report has been
added to ResearchAndMarkets.com’s offering.

The report highlights all important opportunities for generic companies
based on the latest Para IV litigation updates. The analyses provides an
insight into each product opportunity for generic companies in terms of
(1) likely timeline of the first generic launch in US (2) potential
competition on the first day of launch and (3) companies likely to
benefit in case of a probable launch under low competition.

The analyses gets updated every time when an important product
development in Para IV litigation happens. In other words, it is not
only comprehensive but also updated. This report is published every
month covering important updates on Para IV litigations.

Important Para IV events are following events related to Para IV
litigations:

  • New Para IV applications filed
  • Litigation dismissals
  • Final judgments
  • Patent related opinions and judgments
  • PTAB updates

Sources of information:

  • US Courts documents
  • Company SEC filings/Annual Reports
  • USFDA
  • USPTO
  • PTAB

Companies covered in previous issues include:

  • Actavis
  • Alkem
  • Alvogen
  • Amneal
  • Apotex
  • Aurobindo
  • Bion pharma Lupin
  • Cipla
  • Dr Reddy’s
  • Emcure
  • Fresenius Kabi
  • Hetero
  • Jubiliant
  • Lupin
  • Medicare
  • MSN Labs
  • Mylan
  • Natco
  • Par
  • Perrigo
  • Pharma
  • Quilu
  • Sandoz
  • Shilpa
  • SigmaPharma
  • Teva
  • Teva Actavis
  • Torrent
  • Twi
  • Watson
  • Zydus Cadila

For more information about this report visit https://www.researchandmarkets.com/research/frm3cg/global_generic?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Generic
Drugs